Cumulus cell microRNA expression when LH is added to the ovarian stimulation protocol: a pilot study

被引:3
作者
Vigo, Francieli Maria [1 ]
Fraietta, Renato [2 ]
Rodrigues, Fernanda [1 ,3 ]
Carvalho, Cristina, V [1 ]
Bonetti, Tatiana C. S. [1 ]
Motta, Eduardo L. A. [1 ,3 ]
机构
[1] Univ Fed Sao Paulo, Dept Ginecol, Escola Paulista Med, UNIFESP EPM, Rua Napoleao Barros,608 Vila Clementino, BR-04024002 Sao Paulo, SP, Brazil
[2] Univ Fed Sao Paulo, Setor Integrad Reprod Humana, UNIFESP EPM, Escola Paulista Med,Dept Cirurgia, Rua Botucatu,725 Vila Vila Clementino, BR-04024002 Sao Paulo, SP, Brazil
[3] Huntington Med Reprod, Av Republ Libano 529 Ibirapuera, BR-04501000 Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
MicroRNA; Ovarian stimulation; PCR array; Recombinant LH; GRANULOSA-CELLS; OOCYTE; FERTILIZATION; MATURATION; HORMONE; MIRNAS; IVF;
D O I
10.1016/j.rbmo.2021.07.014
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Research question: Recombinant FSH administration in ovarian stimulation for IVF is a standard procedure, whereas the role of LH is controversial. MicroRNAs (mRNA) are small endogenous non-coding transcripts that are involved in the regulation of many cellular processes, including foliculogenesis and gonadotrophin function. The aim was to study the possible role of miRNA in ovarian follicular development in groups having different ovarian stimulation protocols. Are there different miRNA expression profiles in cumulus cells of infertile women undergoing IVF? What are the regulated pathways? Design: This prospective observational study included 13 patients who fulfilled the following inclusion criteria: younger than 38 years of age; a tubal infertility factor; a male factor; or idiopathic infertility. This is a pilot study in which the patients were aleatory enrolled into two groups: seven in FSH group (recombinant FSH, 225 IU) and six in FSH plus LH group (recombinant FSH, 150 IU + recombinant LH, 75 IU). The granulosa cells obtained from the follicular ovarian retrieval were analysed using polyerase chain reaction. Results were analysed using DIANA Tools, an online bioinformatics tool. Results: Among the 84 microRNAs evaluated, 11 were differentially expressed between the groups, all of which were upregulated in the FSH plus LH group, compared with the FSH group. Differentially expressed miRNA profiles are related to oestrogen signalling, oocyte meiosis and pluripotent cells regulation. Conclusion: miRNA overexpression in the FSH plus LH group is consistent with the independent and fundamental role of LH in folliculogenesis, leading to a distinct molecular response between groups.
引用
收藏
页码:1070 / 1077
页数:8
相关论文
共 50 条
  • [41] Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval
    Kao, Tzu-Ching
    Hsieh, Yun-Chiao
    Yang, Ih-Jane
    Wu, Ming-Yih
    Chen, Mei -Jou
    Yang, Jehn-Hsiahn
    Chen, Shee-Uan
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (01) : 29 - 35
  • [42] Intensified ovarian stimulation in a GnRH antagonist protocol with agonist triggering: a prospective, clinical feasibility study
    Griesinger, Georg
    Berndt, Henriette
    Schultz, Laura
    Schultze-Mosgau, Askan
    Diedrich, Klaus
    von Otte, Soeren
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2011, 22 (02) : 133 - 139
  • [43] Higher Pregnancy Success Rates in Patients with Diminished Ovarian Reserve < 40 Years When Initially Treated by Intrauterine Insemination with Mild Ovarian Stimulation Compared to In Vitro Fertilization Alone: A Pilot Study
    Deneer, Julia J. M.
    Le Cessie, Saskia
    van Santbrink, Evert J. P.
    van der Westerlaken, Lucette A. J.
    Lashley, Eileen E. L. O.
    [J]. REPRODUCTIVE SCIENCES, 2025,
  • [44] Clomiphene citrate reduces premature LH surge in obese women during controlled ovarian stimulation: a retrospective cohort study
    Zeng, Yuqi
    Huang, Yuting
    Liu, Yali
    Shen, Xi
    Nie, Yunhan
    Wang, Li
    Kuang, Yanping
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [45] A retrospective, matched case-control study of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol
    Chen, Ming-Jer
    Yi, Yu-Chiao
    Guu, Hwa-Fen
    Chen, Ya-Fang
    Kung, Hsiao-Fan
    Chang, Jui-Chun
    Chuan, Shih-Ting
    Chen, Li-Yu
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [46] MicroRNA expression profiles in peri-miniscrew implant crevicular fluid in orthodontics: a pilot study
    He, Wendan
    Yang, Yanru
    Cai, Longgan
    Lei, Qiaoling
    Wang, Zhongdong
    Che, Xiaoxia
    [J]. BMC ORAL HEALTH, 2021, 21 (01)
  • [47] Dysregulated microRNA Expression Relevant to TERT Promoter Mutations in Tonsil Cancer-A Pilot Study
    Kwon, Mi Jung
    Park, Ha Young
    Lee, Joong Seob
    Kim, Eun Soo
    Kim, Nan Young
    Nam, Eun Sook
    Cho, Seong Jin
    Kang, Ho Suk
    [J]. LIFE-BASEL, 2023, 13 (10):
  • [48] The role of Letrozole (LE) in controlled ovarian stimulation (COS) in patients at high risk to develop ovarian hyper stimulation syndrome (OHSS). A prospective randomized controlled pilot study
    Tshzmachyan, Ruzanna
    Hambartsoumian, Eduard
    [J]. JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2020, 49 (02)
  • [49] Double HCG trigger improves recovery of oocytes in women with a paucifollicular response to ovarian stimulation: A pilot study
    Tesarik, Jan
    Galan-Lazaro, Maribel
    Mendoza, Nicolas
    Mendoza-Tesarik, Raquel
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 157 (01) : 149 - 153
  • [50] Controlled ovarian stimulation and progesterone supplementation affect vaginal and endometrial microbiota in IVF cycles: a pilot study
    Carosso, Andrea
    Revelli, Alberto
    Gennarelli, Gianluca
    Canosa, Stefano
    Cosma, Stefano
    Borella, Fulvio
    Tancredi, Annalisa
    Paschero, Carlotta
    Boatti, Lara
    Zanotto, Elisa
    Sidoti, Francesca
    Bottino, Paolo
    Costa, Cristina
    Cavallo, Rossana
    Benedetto, Chiara
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2020, 37 (09) : 2315 - 2326